Provided by Tiger Trade Technology Pte. Ltd.

Solid Biosciences

9.07
-0.4700-4.93%
Post-market: 9.01-0.0600-0.66%19:30 EDT
Volume:855.92K
Turnover:7.82M
Market Cap:972.53M
PE:-4.85
High:9.36
Open:9.36
Low:9.01
Close:9.54
52wk High:11.45
52wk Low:3.79
Shares:107.23M
Float Shares:64.81M
Volume Ratio:1.22
T/O Rate:1.32%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.8709
EPS(LYR):-1.9922
ROE:-65.50%
ROA:-36.38%
PB:2.60
PE(LYR):-4.55

Loading ...

Evolving Tax Rules and New Excise Levies Threaten Solid Biosciences’ Profitability and Cash Flows

TIPRANKS
·
Mar 21

Guggenheim Initiates Solid Biosciences at Buy With $26 Price Target

MT Newswires Live
·
Mar 20

Analysts Conflicted on These Healthcare Names: MoonLake Immunotherapeutics (MLTX), Solid Biosciences (SLDB) and Merck & Company (MRK)

TIPRANKS
·
Mar 20

Solid Biosciences initiated with a Buy at Guggenheim

TIPRANKS
·
Mar 20

Solid Biosciences Price Target Maintained With a $19.00/Share by Needham

Dow Jones
·
Mar 20

Solid Biosciences: De-Risking Duchenne Program and Advancing Gene Therapy Pipeline Supports Buy Rating and $19 Target

TIPRANKS
·
Mar 20

Solid Biosciences (SLDB) Gets a Buy from Chardan Capital

TIPRANKS
·
Mar 20

Solid Biosciences files to sell 42.78M shares of common stock for holders

TIPRANKS
·
Mar 20

Solid Biosciences Inc - Prospectus Filed for Resale of up to 1.3 Mln Shares by Selling Stockholder- SEC Filing

THOMSON REUTERS
·
Mar 20

Solid Biosciences Q4 net loss widens on higher R&D costs

Reuters
·
Mar 20

Solid Biosciences reports Q4 EPS (53c), consensus (52c)

TIPRANKS
·
Mar 20

Solid Biosciences Q4 EPS $(0.53) Misses $(0.50) Estimate

Benzinga Earnings
·
Mar 20

Solid Biosciences Q4 Net Income USD -49.8 Million

THOMSON REUTERS
·
Mar 20

Press Release: Solid Biosciences Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Updates

Dow Jones
·
Mar 20

Solid Biosciences FY2025 net loss widens 39.8% to USD 174.33 million

Reuters
·
Mar 20

U.S. Earnings Preview: After Market Close March 18

Dow Jones
·
Mar 19